SCHEDULE 13G Filed 2026-08-14 Event — SEC 0001104659-26-097417 →

ADAR1 Capital Management, LLC → Amanat Acquisition Corp. AMAN

Stake: — Shares: — Class: Class A Ordinary Shares, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

4 transactions

2 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

11 filings by this filer

10 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 1.00

37,904 shares short · +1365.2% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-02	Amanat Sponsor Holdings LLC	10%+ owner	J	281,250	—	—
2026-07-02	Kulkarni Sandeep Chidambar	director, officer, 10%+ owner	J	281,250	—	—
2026-05-20	Amanat Sponsor Holdings LLC	10%+ owner	Buy	300,000	—	—
2026-05-20	Kulkarni Sandeep Chidambar	director, officer, 10%+ owner	Buy	300,000	—	—

Other 13D/G Filings on Amanat Acquisition Corp.

Filed	Form	Filer	Stake	Shares
2026-08-12	SCHEDULE 13D/A	Amanat Sponsor Holdings LLC	22.50%	2,175,000	view →
2026-06-16	SCHEDULE 13G	RP Investment Advisors LP	—	—	view →
2026-06-11	SCHEDULE 13D	Amanat Sponsor Holdings LLC	24.70%	2,456,250	view →
2026-06-04	SCHEDULE 13G	Sculptor Capital LP	—	—	view →
2026-05-27	SCHEDULE 13G	GREAT POINT PARTNERS LLC	—	—	view →
2026-05-26	SCHEDULE 13G	INTEGRATED CORE STRATEGIES (US) LLC	—	—	view →

Other Filings by ADAR1 Capital Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-08-14	SCHEDULE 13G	Rein Therapeutics, Inc.	—	—	view →
2026-08-14	SCHEDULE 13G	Cyclerion Therapeutics, Inc.	—	—	view →
2026-08-14	SCHEDULE 13G	Pliant Therapeutics, Inc.	—	—	view →
2026-08-14	SCHEDULE 13G	Research Alliance Corporation III	—	—	view →
2026-08-14	SCHEDULE 13G	Editas Medicine, Inc.	—	—	view →
2026-08-14	SCHEDULE 13G	JATT II Acquisition Corp.	—	—	view →
2026-08-14	SCHEDULE 13G	Boundless Bio, Inc.	—	—	view →
2026-06-05	SCHEDULE 13G	Rallybio Corporation RLYB	—	—	view →
2026-06-05	SCHEDULE 13G	InMed Pharmaceuticals, Inc. INM	—	—	view →
2025-04-28	SCHEDULE	Keros Therapeutics, Inc. KROS	13.29%	5,390,964	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →